| Literature DB >> 3499282 |
D Burstein1, E S Handler, J Schindler, J Seals, J P Mordes, A A Rossini.
Abstract
Young diabetes prone BB/Wor rats were treated for 4-7 weeks with low dose (1,000 units/week) or high dose (75,000 units/week) recombinant human interleukin-2 (IL-2) and observed through 150 days of age for the development of spontaneous diabetes mellitus. Comparing treated rats with controls, it was found that IL-2 did not affect the cumulative incidence of diabetes, the age at onset of the disease, or peripheral lymphocyte subset numbers. High dose IL-2 administered to diabetes resistant BB/Wor rats also failed to induce the disease.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3499282
Source DB: PubMed Journal: Diabetes Res ISSN： 0265-5985